LSD
{Acid, Tab, Lucy, Lysergic acid diethylamide}
Put your brand in front of thousands monthly and support the growth of harm reduction.
The Law
Europe
- UK: Illegal. Class A drug.
- Germany: Illegal.
- France: Illegal
- Netherlands: llegal. To possess, distribute, and produce without a license. Personal consumption is legal.
- Spain: Illegal. To possess, distribute, and produce without a license. Personal consumption is legal.
- Russia: Illegal. To possess, distribute, and produce without a license.
America
- USA: Illegal to manufacture, buy, possess or distribute without a DEA license. Schedule I drug.
- Canada: Illegal to possess, distribute, and produce without a license. Schedule III drug.
- Mexico: Illegal. Personal possession of up to 15 µg is decriminalised.
Asia
- Hong Kong: Illegal. Schedule 1. To manufacture, buy, possess, distribute or consume. Can only be used legally by health professionals and for university research purposes.
- Singapore: Illegal) To possess, consume, import, export and use.
- Israel: Illegal. To possess, manufacture, sell, distribute and use.
Africa
- South Africa: Illegal. To manufacture, possess, consume, import, export and use.
Oceania
- New Zealand: Illegal to manufacture, sale and use. Class A drug.
- Australia: Illegal to manufacture, possess, use and supply.
References
1 Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., ... & Nutt, D. J. (2016). The paradoxical psychological effects of lysergic acid diethylamide (LSD). Psychological medicine, 46(07), 1379-1390.
2 Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R. (2016). Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 30(12), 1268-1278.
3 Murray, R. M., Paparelli, A., Morrison, P. D., Marconi, A., & Di Forti, M. (2013). What can we learn about schizophrenia from studying the human model, drug?induced psychosis?. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 162(7), 661-670.
4 Network, NEPTUNE. Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances. 2015 http://neptune-clinical-guidance.co. uk/wp-content/uploads/2015/03.NEPTUNE-Guidance-March-2015.pdf)
5 Kaelen, M., Barrett, F. S., Roseman, L., Lorenz, R., Family, N., Bolstridge, M., ... & Carhart-Harris, R. L. (2015). LSD enhances the emotional response to music. Psychopharmacology, 232(19), 3607-3614.
6 Kaelen, M., Roseman, L., Kahan, J., Santos-Ribeiro, A., Orban, C., Lorenz, R., ... & Wall, M. B. (2016).LSD modulates music-induced imagery via changes in parahippocampal connectivity. European Neuropsychopharmacology, 26(7), 1099-1109.
7 Lebedev, A. V., Kaelen, M., Lövdén, M., Nilsson, J., Feilding, A., Nutt, D. J., & Carhart‐Harris, R. L. (2016). LSD‐induced entropic brain activity predicts subsequent personality change. Human brain mapping, 37(9), 3203-3213.
8 Speth, J., Speth, C., Kaelen, M., Schloerscheidt, A. M., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. (2016). Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide. Journal of Psychopharmacology, 30(4), 344-353.
9 Leary, T., Metzner, R., & Dass, R. (1966).The psychedelic experience.Smithsonian Folkways Recordings.
10 Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., Bolstridge, M., Feilding, A., & Nutt, D. J. (2015). LSD enhances suggestibility in healthy volunteers. Psychopharmacology, 232(4), 785-794.
11 Tagliazucchi, E., Roseman, L., Kaelen, M., Orban, C., Muthukumaraswamy, S. D., Murphy, K., ... & Bullmore, E. (2016).Increased global functional connectivity correlates with LSD-Induced ego dissolution. Current Biology,26(8), 1043-1050.
12 Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., ... & Leech, R. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging.Proceedings of the National Academy of Sciences, 113(17), 4853-4858.
13 Roseman, L., Sereno, M. I., Leech, R., Kaelen, M., Orban, C., McGonigle, J., ... & Carhart‐Harris, R. L. (2016). LSD alters eyes‐closed functional connectivity within the early visual cortex in a retinotopic fashion.Human brain mapping, 37(8), 3031-3040.
14 Terhune, D. B., Luke, D. P., Kaelen, M., Bolstridge, M., Feilding, A., Nutt, D., ... & Ward, J. (2016). A placebo-controlled investigation of synaesthesia-like experiences under LSD. Neuropsychologia.
15 Family, N., Vinson, D., Vigliocco, G., Kaelen, M., Bolstridge, M., Nutt, D. J., & Carhart-Harris, R. L. (2016). Semantic activation in LSD: evidence from picture naming.Language, Cognition and Neuroscience, 1-8.
16 Dolder, P. C., Schmid, Y., Müller, F., Borgwardt, S., & Liechti, M. E. (2016). LSD acutely impairs fear recognition and enhances emotional empathy and sociality. Neuropsychopharmacology, 41(11), 2638.
17 Nichols, D. E. (2016). Psychedelics.Pharmacological reviews, 68(2), 264-355.
18 Strassman, R. J. (1984). Adverse reactions to psychedelic drugs. A review of the literature. J Nerv Ment Dis, 172(10), 577-595.
19 Halberstadt, A. L. (2015).Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behavioural brain research, 277, 99-120.
20 Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 0269881114548296
21 Garcia-Romeu, A., R Griffiths, R., & W Johnson, M. (2014). Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.Current drug abuse reviews, 7(3), 157-164.
22 Krebs, T. S., & Johansen, P. Ø. (2013). Psychedelics and mental health: a population study. PloS one, 8(8), e63972.
23 Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015). Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology, 29(3), 280-288.
24 Johansen, P. Ø., & Krebs, T. S. (2015).Psychedelics not linked to mental health problems or suicidal behavior: A population study. Journal of Psychopharmacology, 0269881114568039.
Put your brand in front of thousands monthly and support the growth of harm reduction.